KEYSTONE DENTAL GROUP
NEWS

Keystone Dental Group Announces Strategic Partnership and Initiatives with Milestone Scientific

New Collaboration to Expand the STA Single Tooth Anesthesia® System within Implant Dentistry
April 14, 2022 7:30 ET

BURLINGTON, MASS., April 13, 2022 - Keystone Dental Holdings, Inc. (“Keystone Dental”), a global commercial stage medical technology company with a comprehensive portfolio of tooth replacement solutions comprised of implants, prosthetic solutions, biomaterial solutions, and digital dentistry capabilities, announced today that the company has collaborated with Milestone Scientific to become a strategic channel partner for its STA Single Tooth Anesthesia® System.

Arjan Haverhals, CEO of Milestone Scientific Inc. commented, “We are delighted to announce a series of key initiatives to expand domestic distribution of the STA Single Tooth Anesthesia system. Keystone Dental Group is an ideal strategic channel partner given their dedicated sales force and broad reach across the U.S. Implant dentistry is a natural fit for the STA Single Tooth Anesthesia system, since it allows for localized anesthesia across a wide range of dental procedures. Through the use of our STA Single Tooth Anesthesia system, implant dentistry can be performed without the discomfort or potential risks and complications that could occur when numbing an entire quadrant of the patient’s mouth. Keystone Dental Group has a proven track record of introducing new products, including specialized instruments that require hands on training and support.”

Melker Nilsson, CEO of Keystone Dental, stated, “Keystone is very pleased to work with a leading partner in Milestone Scientific. This collaboration provides potential for improved patient care by embracing solutions that create a better, more comfortable patient experience and provide our customers with unique tools that enhance their daily workflow. We look forward to introducing these new capabilities from the STA Single Tooth Anesthesia system across our sales force and customer base.”

About Milestone Scientific, Inc.
Milestone Scientific Inc. (MLSS), a technology focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

About Keystone Dental Holdings, Inc.
Keystone Dental Group is a global commercial stage medical technology company focused on providing end-to-end solutions for dental practitioners and tooth replacement procedures. Headquartered in Burlington, Massachusetts with a distribution facility in Irvine, California, and a research and development and manufacturing site in Caesarea, Israel and in Melbourne, Australia, Keystone Dental Group markets its products across the world. The Company’s comprehensive portfolio of tooth replacement solutions is comprised of implants, prosthetic solutions, biomaterial solutions and digital dentistry capabilities. It includes proprietary offerings such as Osteon, Nexus iOS, Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® extracellular membrane, and the Dyna Blast® and DynaGraft D® bone graft substitutes. Keystone Dental Group acquired Implant Solutions Pty Ltd (“Osteon”) in 2021, adding a comprehensive portfolio of prosthetic solutions on implants and digital workflow capabilities. For more information, refer to www.keystonedental.com.


Contact:
Leigh Salvo
Gilmartin Group
leigh@gilmartinir.com

Keystone Dental Strengthens Leadership Team with Addition of Two Key Executives

Appointments of Vice President of R&D and Head of Canadian Sales Underscores Company’s Continued Commitment to Innovation and International Expansion
February 24, 2022 13:00 ET

BURLINGTON, MASS., February 24, 2022 - Keystone Dental Holdings, Inc. (“Keystone Dental”), a global commercial stage medical technology company with a comprehensive portfolio of tooth replacement solutions comprised of implants, prosthetic solutions, biomaterial solutions, and digital dentistry capabilities, announced that effective March 1, 2022 Ofer Zigman joins the Company as Vice President of R&D and Kishore Pranjivan joins the Company as Country Manager Canada.

Melker Nilsson, CEO of Keystone Dental commented: “We are very excited to welcome Kishore and Ofer to the Keystone leadership team. Geographical expansion and continuous innovation are key components of our growth strategy as we emerge in the market as a global provider of tooth replacement solutions. I am very pleased to add two distinguished individuals in their respective roles to lead these facets of our business.”

Mr. Zigman, who assumes responsibility for Keystone’s Israeli development team, brings more than 15 years of executive level experience in the medical device industry that included seven years leading R&D teams in the dental implant industry. In this new role at Keystone Dental, Mr. Zigman will primarily focus on R&D and product management. He will also oversee the development of new products and support the acceleration of Keystone Dental’s development pipeline. Most recently Mr. Zigman served as VP of R&D at Hospitech Respiration formulating the company’s innovation roadmap and execution. Prior to that, he was the VP of Product and R&D at AlphaBio Tec (ABT), where he led dental implant developments and go-to-market strategy. Before AlphaBio Tec, he was the VP of R&D at Xenolith Medical where he oversaw product development from concept to commercialization.

Mr. Pranjivan assumes responsibility for the establishment and development of Keystone Dental’s direct sales organization in Canada. Mr. Pranjivan has more than 30 years of experience in the dental market, including more than 20 years of senior-level manager and director roles within Nobel Biocare. During his tenure with Nobel Biocare Mr Pranjivan held various subsidiary roles, such as Regional Director in Australia and Asia, Country Manager in Canada and Regional Director in UK and Ireland.

Most recently, Mr. Pranjivan held a position of Director of Special Markets and Institutions at Henry Schein Canada. In this role, his key focus was development and support of group practices and DSO’s in Canada


About Keystone Dental Holdings, Inc.
Keystone Dental is a global commercial stage medical technology company focused on providing end-to-end solutions for dental practitioners and tooth replacement procedures. Headquartered in Burlington, Massachusetts with a distribution facility in Irvine, California, and a research and development and manufacturing site in Caesarea, Israel and in Melbourne, Australia, Keystone Dental markets its products across the world. The Company’s comprehensive portfolio of tooth replacement solutions is comprised of implants, prosthetic solutions, biomaterial solutions and digital dentistry capabilities. It includes proprietary offerings[1] such as Osteon, Nexus iOS, Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® extracellular membrane, and the Dyna Blast® and DynaGraft D® bone graft substitutes. Keystone acquired Implant Solutions Pty Ltd (“Osteon”) in 2021, adding a comprehensive portfolio of prosthetic solutions on implants and digital workflow capabilities. For more information, refer to www.keystonedental.com.


Contact:
Leigh Salvo
Gilmartin Group
leigh@gilmartinir.com

Keystone Dental Appoints Sheryl Conley to its Board of Directors

Keystone Dental Appoints Sheryl Conley to its Board of Directors
February 28, 2022 13:00 ET

BURLINGTON, MASS., February 28, 2022 - Keystone Dental Holdings, Inc. (“Keystone Dental”), a global medical technology company with a comprehensive portfolio of tooth replacement solutions comprised of implants, prosthetic solutions, biomaterial solutions, and digital dentistry capabilities, announced the appointment of Sheryl Conley to the company’s Board of Directors, effective February 25, 2022.

Dr. Uri Geiger, Chairman of Keystone’s Board commented: “We are delighted to welcome Sheryl to Keystone and our board of directors. Sheryl brings to the board more than 35 years of healthcare industry experience, with specific expertise in operations, product development, global brand management, and sales. Her vast executive and board experience will be an invaluable asset to leverage as the company moves ahead towards solidifying its place as a leader in the tooth replacement market. With Sheryl’s joining, Keystone has completed the formation of independent and diversified high caliber board”

Ms. Conley spent 25 years with Zimmer, Inc. in escalating management roles including Group President, Americas and Global Brand Management, and Chief Marketing Officer. In these roles, Ms. Conley worked across numerous product segments, including responsibility for the Dental Division, and geographies managing and developing commercial releases of over 50 industry leading brands. She currently serves as a public board director for Neuronetics, Inc., Surgalign Holdings, Inc., and Anika Therapeutics, Inc. Sheryl received a Bachelor of Science in Biology and Chemistry and a Master of Business Administration from Ball State University. 

About Keystone Dental Holdings, Inc.
Keystone Dental is a global commercial stage medical technology company focused on providing end-to-end solutions for dental practitioners and tooth replacement procedures. Headquartered in Burlington, Massachusetts with a distribution facility in Irvine, California, and a research and development and manufacturing site in Caesarea, Israel and in Melbourne, Australia, Keystone Dental markets its products across the world. The Company’s comprehensive portfolio of tooth replacement solutions is comprised of implants, prosthetic solutions, biomaterial solutions and digital dentistry capabilities. It includes proprietary offerings such as Osteon, Nexus iOS, Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® extracellular membrane, and the Dyna Blast® and DynaGraft D® bone graft substitutes. Keystone acquired Implant Solutions Pty Ltd (“Osteon”) in 2021, adding a comprehensive portfolio of prosthetic solutions on implants and digital workflow capabilities. For more information, refer to www.keystonedental.com.

Contact:
Leigh Salvo
Gilmartin Group
leigh@gilmartinir.com

Keystone Dental Appoints Senior Vice President of International Sales

Keystone Dental Appoints Senior Vice President of International Sales
November 01, 2021 13:00 ET

BURLINGTON, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Keystone Dental Holdings, Inc. (“Keystone Dental”), a global commercial stage medical technology company with a comprehensive portfolio of tooth replacement solutions comprised of implants, prosthetic solutions, biomaterial solutions, and digital dentistry capabilities, announced today that Mark Neri has been appointed Senior Vice President International Sales.

Mr. Neri assumes responsibility for all of the Keystone Dental’s implants systems, as well as the company’s regenerative product portfolio. In his new role, Mr. Neri will drive Keystone Dental’s continued expansion of offerings in international geographies, with oversight of direct sales professionals in select international geographies and third-party distributors in other regions.

Mr. Neri has developed and led high-performance teams in the dental device and related industries for more than 30 years, including as SVP of International Sales for BioHorizons Implant Systems. Most recently, Mr. Neri was President of the Americas for Neoss, Inc., a dental solutions company.

Melker Nilsson, CEO of Keystone Dental, commented: “We welcome Mark to the Keystone team. We are confident that his extensive knowledge and experience in the global dental industry, combined with his worldwide connections, will support our intention to expand our footprint while simultaneously aiding the existing network to increase visibility and sales through customer focused management, education and marketing.”

About Keystone Dental Holdings, Inc.

Keystone Dental is a global commercial stage medical technology company focused on providing end-to-end solutions for dental practitioners and tooth replacement procedures. Headquartered in Burlington, Massachusetts with a distribution facility in Irvine, California, and a research and development and manufacturing site in Caesarea, Israel, Keystone Dental markets its products across the world. The company’s product portfolio includes proprietary offerings such as Osteon, Nexus iOS, Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® extracellular membrane, and the Dyna Blast® and DynaGraft D® bone graft substitutes. Keystone acquired Implant Solutions Pty Ltd (“Osteon”) in 2021, adding a comprehensive portfolio of prosthetic solutions on implants and digital workflow capabilities. For more information, refer to www.keystonedental.com.

Contact:
Leigh Salvo
Gilmartin Group
leigh@gilmartinir.com 

Keystone Dental Announces Completion of $25 Million Financing to Accelerate Growth of Dental Implant and Digital Dentistry Portfolio

Keystone Dental Announces Completion of $25 Million Financing to Accelerate Growth of Dental Implant and Digital Dentistry Portfolio
September 01, 2021 07:15 ET

BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Keystone Dental Inc. (“Keystone”), the largest independent dental implant company operating in North America, today announced a $25 million financing. The financing round was led by Nantahala, with participation from Accelmed and Accelmed’s anchor investor, Migdal Insurance.

Proceeds from the financing were used to support Keystone’s acquisition of Osteon Medical, a commercial stage leader in breakthrough dental implant solutions. In addition, remaining funds will be used for continued growth, including market expansion activities and other strategic investments. Key areas of focus are a highly innovative dental implant product portfolio in combination with market leading digital capability.

“It is a great honor to have such strong support from well-known investors on our journey of providing the global dental implant market with a comprehensive, world-class portfolio,” said Melker Nilsson, CEO of Keystone. “These funds provide us with the additional capital we need for the acquisition of Osteon Medical. In addition, this financing delivers us working capital for the further acceleration of our anticipated growth, including exploration of organic as well as other in-organic initiatives within the dental implant market. We are very excited about the opportunities ahead.”

Dr. Uri Geiger, Managing Partner at Accelmed and Chairman of Keystone, commented, “In just three years, Keystone’s leadership team, supported by Accelmed, executed a complete turnaround of the business, transforming it into a rapidly-growing company rife with innovation and a market leader in the premium-value dental segment in the US. The acquisitions of Paltop Advanced Dental Solutions LTD in 2019 and Osteon Medical, announced earlier today, further establish Keystone’s leadership position in this $5 billion market opportunity. We are confident that these growth initiatives, combined with robust digital capabilities, and a premium-value product portfolio, ensure that Keystone is well-poised for continued growth.”

About Accelmed Partners
Accelmed is a U.S.-based private equity firm focused on acquiring and investing in U.S. commercial stage, lower middle market HealthTech companies. Since 2009, Accelmed has deployed over $400 million into companies spanning medical devices, diagnostics, digital health and technology-enabled healthcare services, Accelmed seeks to accelerate value and scale innovation across the HealthTech field by bringing to bear the team’s industry experience, operational and financial expertise, and strong global relationships. For more information, please visit https://www.accelmed.com

About Keystone Dental Inc.
Keystone Dental is an oral healthcare company dedicated to the delivery of breakthrough dental implant, biomaterial technologies and providing a highly innovative digital workflow. Headquartered in Burlington, Massachusetts with manufacturing and distribution facilities in Irvine, California, Keystone markets its products worldwide and is the largest independent dental implant company in North America. The company’s product portfolio includes proprietary offerings such as Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® Extracellular Membrane, and the DynaBlast® and DynaGraft® bone graft substitutes. For more information, refer to www.keystonedental.com

Contacts:
Leigh Salvo
Gilmartin Group
leigh@gilmartinir.com

Amanda Klein/Alex Jeffrey
Gasthalter & Co.
(212) 257-4170
Accelmed@gasthalter.com

Keystone Dental Announces Acquisition of Osteon Medical

Keystone Dental Announces Acquisition of Osteon Medical
September 01, 2021 07:00 ET
  • Significantly increases Keystone's global visibility in the dental market with innovative solutions and a premium-value proposition
  • Provides Keystone a synergistic sales opportunity to expand in the $5 billion dental implant market

  • Enhances Keystone’s platform with easy-to-use, innovative and unique digital solutions that increase accuracy and treatment efficiencies

BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Keystone Dental Inc. (“Keystone”), the largest independent dental implant company operating in North America, announced today that it has completed the acquisition of Osteon Medical, a Melbourne, Australia-based technology company providing digital solutions for clinicians and dental laboratories leveraging proprietary software and unique hardware developments, significantly improving digital workflows.

The transaction significantly increases Keystone's global visibility in the dental market with innovative solutions and a high value proposition. In addition, it immediately provides Keystone with the opportunity to market a full-arch implant portfolio through dedicated production facilities in both Melbourne and Osaka, Japan. Osteon’s newly patented Nexus iOS mapping technology and scanning system provides the first of its kind digital solutions to dentists and dental laboratories across the world. In addition, Osteon’s continued innovation has resulted in rapid growth while seeking international expansion as new distribution channels are established throughout Europe and Asia.

“In our ongoing search for exceptional business partners, we are very pleased to be combining forces with Osteon Medical,” said Melker Nilsson, CEO of Keystone. “The combination of Keystone and Osteon enables us to offer a more comprehensive portfolio of unique and innovative solutions for our customers and partners, in particular when it comes to digital workflows, increased efficiency and improved accuracy. The acquisition further provides Keystone with a significantly expanded and synergistic implant sales opportunity to both existing and new customers.

“We welcome Michael Tuckman, CEO of Osteon Medical, and his colleagues to Keystone and highly value the business they have built,” concluded Nilsson.

“Keystone is the perfect partner for Osteon Medical as their leading dental implant offerings are combined with our full-arch dental prosthesis portfolio”, said Michael Tuckman, CEO of Osteon Medical. “Our mission at Osteon Medical fully aligns with that of Keystone – to simplify complex procedures through innovation and technological improvements and to deliver tomorrow's solutions today.”

The combined companies will continue to operate independently as separate businesses while supporting Keystone Dental’s expanding digital product offerings for its premium and value market segments. The terms of the acquisition were not disclosed.

About Osteon Medical
Osteon Medical, a commercial stage leader in digital dental implant solutions, develops innovative and advanced customized implant retained prosthetics and advanced engineering solutions based on propriety CAD/CAM scanning and design technology. The result delivers a much more efficient, shorter and accurate complex implementation procedure. Osteon’s solution includes a scanning component, AI based-CAD/CAM design software, 3D printing of the tooth and augmented reality supported implantation procedure. Osteon is headquartered in Melbourne, Australia and supported by dedicated production facilities in both Melbourne and Osaka, Japan. The company’s products are available in Japan, Europe, and pending FDA clearance, are expected to launch in the U.S. in early 2022.

About Keystone Dental Inc.
Keystone Dental is an oral healthcare company dedicated to the delivery of breakthrough dental implant and biomaterial technologies. Headquartered in Burlington, Massachusetts with manufacturing and distribution facilities in Irvine, California, Keystone markets its products worldwide and is the largest independent dental implant company in North America. The company’s product portfolio includes proprietary offerings such as Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® Extracellular Membrane, and the DynaBlast® and DynaGraft® bone graft substitutes. For more information, refer to www.keystonedental.com.

Contacts:
Leigh Salvo
Gilmartin Group
leigh@gilmartinir.com

BACK TO TOP